Further data showed that increased generation of C18-ceramide via overexpression of CERS1 or adding exogenous of C18-ceramide resulted in the inhibition of cell viability, which involved the activation of ER stress, induction of autophagy, and modulation of the PI3K/AKT pathway in glioma cells. The gene discussed is CERS1; the disease is central nervous system cancer.